» Articles » PMID: 18551127

Distribution of Subcutaneous Fat Predicts Insulin Action in Obesity in Sex-specific Manner

Overview
Date 2008 Jun 14
PMID 18551127
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The pattern of adipose tissue (AT) distribution is an important predictor of metabolic risk. The aim of this study was to analyze the association of peripheral (insulin-mediated glucose disposal--M) and hepatic (suppression of endogenous glucose production--EGP) insulin action with abdominal (subcutaneous abdominal AT-SAAT intraabdominal AT-IAAT) and thigh AT depots in obese individuals. Fifty-seven Pima Indians with normal glucose tolerance underwent magnetic resonance imaging (MRI) and euglycemic-hyperinsulinemic clamp. M was negatively related to intraperitoneal IAAT (P = 0.02) and deep SAAT (P = 0.03). Suppression of EGP was negatively related to total (P < 0.05) or deep SAAT (P < 0.05 and P = 0.01, respectively), and total or intraperitoneal IAAT (P = 0.009 and P = 0.002, respectively). A significant interaction with sex was found in the association between superficial SAAT and M, so that in women, but not men, M negatively correlated with superficial SAAT (P = 0.02). In stepwise regression analysis, both M (r2 = 0.09) and EGP suppression (r2 = 0.17) were associated only with intraperitoneal IAAT in the whole group. In the sex-specific analysis (because of the significant interaction), lower M was associated with higher deep SAAT (r2 = 0.15) in combination with lower superficial SAAT (r2 = 0.09) in men, and with higher superficial SAAT (r2 = 0.29) in combination with lower thigh subcutaneous AT (r2 = 0.16) in women. Although intraperitoneal IAAT and deep SAAT were major predictors of peripheral and hepatic insulin action in obese Pima Indians, the largest variance in M rate was explained in a sex-specific manner by relative size of subcutaneous AT depots.

Citing Articles

A modelling approach to hepatic glucose production estimation.

Panunzi S, De Gaetano A PLoS One. 2022; 17(12):e0278837.

PMID: 36542610 PMC: 9770442. DOI: 10.1371/journal.pone.0278837.


Keeping It Local in Metabolic Disease: Adipose Tissue Paracrine Signaling and Insulin Resistance.

Kahn D, Bergman B Diabetes. 2022; 71(4):599-609.

PMID: 35316835 PMC: 8965661. DOI: 10.2337/dbi21-0020.


Intraperitoneal, but not retroperitoneal, visceral adipose tissue is associated with diabetes mellitus: a cross-sectional, retrospective pilot analysis.

Tanaka M, Okada H, Hashimoto Y, Kumagai M, Nishimura H, Fukui M Diabetol Metab Syndr. 2020; 12(1):103.

PMID: 33292449 PMC: 7691054. DOI: 10.1186/s13098-020-00612-5.


Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data.

Baik I Diabetes Metab J. 2018; 43(1):90-96.

PMID: 30398038 PMC: 6387874. DOI: 10.4093/dmj.2018.0043.


Body Fat Distribution and the Risk of Incident Metabolic Syndrome: A Longitudinal Cohort Study.

Kwon H, Kim D, Kim J Sci Rep. 2017; 7(1):10955.

PMID: 28887474 PMC: 5591218. DOI: 10.1038/s41598-017-09723-y.


References
1.
Lillioja S, Bogardus C . Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev. 1988; 4(5):517-40. DOI: 10.1002/dmr.5610040508. View

2.
Monzon J, Basile R, Heneghan S, Udupi V, Green A . Lipolysis in adipocytes isolated from deep and superficial subcutaneous adipose tissue. Obes Res. 2002; 10(4):266-9. DOI: 10.1038/oby.2002.36. View

3.
Tataranni P, Ravussin E . Use of dual-energy X-ray absorptiometry in obese individuals. Am J Clin Nutr. 1995; 62(4):730-4. DOI: 10.1093/ajcn/62.4.730. View

4.
Ostman J, Arner P, Engfeldt P, Kager L . Regional differences in the control of lipolysis in human adipose tissue. Metabolism. 1979; 28(12):1198-205. DOI: 10.1016/0026-0495(79)90131-8. View

5.
Ross R, Aru J, Freeman J, Hudson R, Janssen I . Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab. 2002; 282(3):E657-63. DOI: 10.1152/ajpendo.00469.2001. View